Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 2
2004 3
2005 4
2006 7
2007 6
2008 10
2009 11
2010 13
2011 10
2012 7
2013 12
2014 13
2015 18
2016 15
2017 13
2018 16
2019 19
2020 33
2021 15
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.
Convertino I, Cazzato M, Tillati S, Giometto S, Gini R, Valdiserra G, Cappello E, Ferraro S, Bonaso M, Bartolini C, Paoletti O, Lorenzoni V, Trieste L, Filippi M, Turchetti G, Cristofano M, Blandizzi C, Mosca M, Lucenteforte E, Tuccori M. Convertino I, et al. Among authors: blandizzi c. Front Pharmacol. 2023 Sep 25;14:1244486. doi: 10.3389/fphar.2023.1244486. eCollection 2023. Front Pharmacol. 2023. PMID: 37818193 Free PMC article.
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.
Convertino I, Lorenzoni V, Gini R, Turchetti G, Fini E, Giometto S, Bartolini C, Paoletti O, Ferraro S, Cappello E, Valdiserra G, Bonaso M, Blandizzi C, Tuccori M, Lucenteforte E. Convertino I, et al. Among authors: blandizzi c. Pharmaceuticals (Basel). 2023 Mar 21;16(3):465. doi: 10.3390/ph16030465. Pharmaceuticals (Basel). 2023. PMID: 36986565 Free PMC article.
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study.
Convertino I, Giometto S, Gini R, Cazzato M, Fornili M, Valdiserra G, Cappello E, Ferraro S, Bartolini C, Paoletti O, Tillati S, Baglietto L, Turchetti G, Trieste L, Lorenzoni V, Blandizzi C, Mosca M, Tuccori M, Lucenteforte E. Convertino I, et al. Among authors: blandizzi c. J Clin Med. 2021 Dec 8;10(24):5743. doi: 10.3390/jcm10245743. J Clin Med. 2021. PMID: 34945038 Free PMC article.
Donepezil improves vascular function in a mouse model of Alzheimer's disease.
Pellegrini C, D'Antongiovanni V, Fornai M, Duranti E, Baldacci F, Bernardini N, Taddei S, Virdis A, Blandizzi C, Masi S, Antonioli L. Pellegrini C, et al. Among authors: blandizzi c. Pharmacol Res Perspect. 2021 Dec;9(6):e00871. doi: 10.1002/prp2.871. Pharmacol Res Perspect. 2021. PMID: 34713597 Free PMC article.
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases.
Convertino I, Cazzato M, Giometto S, Gini R, Valdiserra G, Cappello E, Ferraro S, Tillati S, Bartolini C, Paoletti O, Lorenzoni V, Trieste L, Filippi M, Turchetti G, Cristofano M, Blandizzi C, Mosca M, Lucenteforte E, Tuccori M. Convertino I, et al. Among authors: blandizzi c. Sci Rep. 2021 Oct 13;11(1):20314. doi: 10.1038/s41598-021-98321-0. Sci Rep. 2021. PMID: 34645838 Free PMC article.
Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.
Antonioli L, Pellegrini C, Fornai M, Benvenuti L, D'Antongiovanni V, Colucci R, Bertani L, Di Salvo C, Semeghini G, La Motta C, Giusti L, Zallocco L, Ronci M, Quattrini L, Angelucci F, Coviello V, Oh WK, Ha QTK, Németh ZH, Haskó G, Blandizzi C. Antonioli L, et al. Among authors: blandizzi c. Int J Mol Sci. 2021 Jun 13;22(12):6325. doi: 10.3390/ijms22126325. Int J Mol Sci. 2021. PMID: 34199160 Free PMC article.
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity.
Pellegrini C, Fornai M, Benvenuti L, Colucci R, Caputi V, Palazon-Riquelme P, Giron MC, Nericcio A, Garelli F, D'Antongiovanni V, Segnani C, Ippolito C, Nannipieri M, Lopez-Castejon G, Pelegrin P, Haskó G, Bernardini N, Blandizzi C, Antonioli L. Pellegrini C, et al. Among authors: blandizzi c. Br J Pharmacol. 2021 Oct;178(19):3924-3942. doi: 10.1111/bph.15532. Epub 2021 Jun 24. Br J Pharmacol. 2021. PMID: 34000757 Free article.
201 results